Global labs Established multinational footprint with four fully owned harmonized laboratories across US, Europe, Singapore, and China, indicating capacity to support global clinical trials and multi-region studies for potential clients.

Comprehensive testing Extensive portfolio including safety assessments, biomarker development and validation, molecular testing, flow cytometry, pathology, and vaccine support presents multiple cross-sell opportunities to sponsors seeking end‑to‑end central laboratory services.

Clinical trial readiness 40+ years combined experience in standardized, high-quality central lab services and global data harmonization offer a compelling value proposition for sponsors aiming to streamline trial timelines and ensure consistent data quality across sites.

Strategic partnerships History of collaborations with Eurofins and regional expansions (notably Shanghai) suggest openness to partner ecosystems and potential for co‑development or capacity-sharing arrangements to meet growing demand.

Growth signals Revenue in the mid‑range of hundreds of millions and a strong brand lineage in biopharma testing imply scalable operations with room for expanding service lines, capacity, and regional coverage to capture additional trial workloads.